Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-22

FDA Approved: METFORMIN HCL — Supplemental Application (TIME CAP LABORATORIES, INC)

View source ↗

Summary

The FDA approved a supplemental application for METFORMIN HCL by Time Cap Laboratories, Inc., under ANDA 090888. The product is a generic metformin hydrochlorid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HCL (METFORMIN HYDROCHLORIDE)

Snippet

SUPPL AP for METFORMIN HCL (METFORMIN HCL)